Their findings revealed successful inhibition of human lung cancer cell proliferation (A549) and in vivo xenograft tumor growth after the administration of a gold NP complex, achieved through the knockdown of Glut1 that limits glucose uptake [117]. The gene discussed is SLC2A1; the disease is neoplasm.